GlassScriptPhysician profile
Milind R Dhond
NPI 1972500676
$16,648.96
in general payments reported to CMS, 2019-2025
52 companies · $1,928 in 2025
The $1,928 reported for 2025 was more than what 83% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,071 · 2020: $1,325 · 2021: $2,353 · 2022: $2,593 · 2023: $2,602 · 2024: $3,776 · 2025: $1,928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,518 · Honoraria: $1,600 · Education: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,518.21 |
| Honoraria | $1,600.00 |
| Education | $188.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,966.73 | 2019-2025 | Amvia Edge, Acticor 7 Vr-T Dx, Selectra |
| Impulse Dynamics (USA) INC. | $2,338.35 | 2023-2024 | Optimizer, Optimizer |
| Novartis Pharmaceuticals Corporation | $1,067.81 | 2019-2025 | |
| Abbott Laboratories | $816.12 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Merlin@Home, Amplatzer Amulet |
| Amgen INC. | $777.44 | 2019-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $762.37 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $754.34 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $598.86 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $515.46 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $476.09 | 2019-2025 | Farxiga, Wainua |
| Esperion Therapeutics, INC. | $405.05 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $339.13 | 2019-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $294.54 | 2022-2025 | |
| Pfizer INC. | $280.72 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $266.46 | 2019-2025 | Lifevest |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $250.63 | 2022-2025 | Opsumit, Uptravi |
| Atricure, INC. | $229.59 | 2022-2024 | |
| Astellas Pharma US INC | $215.26 | 2021 | |
| Abiomed | $206.89 | 2019-2025 | |
| Boston Scientific Corporation | $198.07 | 2021-2025 | Bodyguardian |
| Medtronic, INC. | $172.14 | 2021-2024 | Venaseal |
| Kiniksa Pharmaceuticals, LTD. | $164.02 | 2021-2023 | Arcalyst |
| Baxter Healthcare | $125.15 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Philips North America LLC | $120.47 | 2023-2025 | (5044) Mcot, (5091) Amb Mon & Diag Und, Mcot |
| Alnylam Pharmaceuticals INC. | $109.56 | 2022-2025 | Amvuttra |
| Cathworks, INC. | $97.80 | 2019-2021 | |
| Viz.Ai, INC. | $86.51 | 2022 | |
| Bridgebio Pharma, INC. | $74.94 | 2025 | Attruby |
| Braemar Manufacturing, LLC | $74.57 | 2019 | |
| Shockwave Medical, INC | $71.20 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biosense Webster, INC. | $71.19 | 2023-2024 | Carto 3, Qdot Micro Catheter |
| Chiesi USA, INC. | $66.49 | 2020-2023 | Kengreal, Cleviprex |
| Inari Medical, INC. | $63.50 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $56.13 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kestra Medical Technology Services, INC. | $54.03 | 2024 | Assure Wcd |
| Heartflow, INC. | $47.00 | 2022-2024 | |
| Lexicon Pharmaceuticals, INC. | $46.38 | 2024 | |
| Scpharmaceuticals INC. | $40.31 | 2023-2024 | |
| Bardy Diagnostics, INC. | $33.40 | 2022 | |
| Ethicon US, LLC | $32.14 | 2020 | |
| Reflow Medical INC | $29.87 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $29.45 | 2024 | Arcalyst |
| Terumo Medical Corporation | $28.99 | 2024 | Azur Cx Detachable |
| Regeneron Healthcare Solutions, INC. | $28.10 | 2019 | |
| Cardiovascular Systems INC. | $27.47 | 2022 | |
| Ge Healthcare | $26.37 | 2025 | |
| Tactile Systems Technology INC | $21.32 | 2024 | Entre Plus, Flexitouch Plus |
| Biogen, INC. | $21.08 | 2024 | Skyclarys |
| Genzyme Corporation | $21.04 | 2022 | |
| Bard Peripheral Vascular, INC. | $20.06 | 2021 | |
| Angiodynamics, INC. | $15.14 | 2022 | |
| Convatec INC. | $13.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milind Dhond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.